Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project

European Journal of Cancer

Volumn 49, Issue 3, 2013, Pages 684-695

  Stiller, C A ^a   Trama, A ^b   Serraino, D ^c   Rossi, S ^d   Navarro, C ^e   Chirlaque, M D ^e   Zielonk, N ^f   Van Eycken, E ^g   Sundseth, H ^h   Hedelin, G ⁱ   Woronoff, A S ^j   Buemi, A ^k   Tretarre, B ^l   Colonna, M ^m   Bara, S ⁿ   Ganry, O ^o   Grosclaude, P ^p   Baconnier, S ^q   Holleczek, B ^r   Geissler, J ^s   Wartenberg, M ^t   Tryggvadottir, L ^u   Deady, S ^v   Bellu F ^w   Ferretti, S ^x   Vercelli, M ^y   Vitarelli, S ^z   Federico, M ^aa   Fusco, M ^ab   Michiara, M ^ac   Giacomin, A ^ad   Tumino, R ^ae   Mangone, L ^af   Falcini, F ^ag   Senatore, G ^ah   Budroni, M ^ai   Piffer, S ^aj   Crocetti, E ^ak   La, F ^al   Contiero, P ^am   Zambon, P ^an   Gatta, G ^b   Gronchi, A ^b   Licitra, L ^b   Ruzza, M ^b   Sowe, S ^b   Capocaccia, R ^d   De Angelis, R ^d   Mallone, S ^d   Tavilla, A ^d   Dei Tos, A P ^ao   Malta, K ^ap   Norway, G ^aq   Rachtan, J ^ar   Gozdz, S ^as   Zwierko, M ^at   Bielska Lasota, M ^au   Slowinski, J ^av   Miranda, A ^aw   Safaei Diba, Ch ^ax   Primic Zakelj, M ^ay   Mateos, A ^az   Izarzugaza, I ^ba   Torrella, A ^bb   Marcos, R ^bc   Ardanaz, Eva ^bd   Galceran, J ^be   Martinez Garcia, C ^bf   Sanchez Perez, M J ^bf   Melchor, J M ^bf   Cervantes, A ^bg   Adolfsson, Jan ^bh   Lambe, M ^bi   Ringborg, Ulrik ^bj   Jundt, G ^bk   Usel, M ^bl   Ess, S M ^bm   Spitale, A ^bn   Konzelmann, I ^bo   Lutz, J M ^bp   Visser, O ^bq   Coebergh, J W W ^br   Otter, R ^bs   Siesling, S ^bs   van der Zwan, J M ^bs   Schouten, H ^bt   Greenberg, D C ^bu   Wilkinson, J ^bv   Roche, M ^bw   Verne, J ^bx   Meechan, D ^by   Lawrence, G ^bz   Coleman, M P ^ca   Mackay, J ^cb   Gavin, A ^cc   Brewster, D H ^cd   Kunkler, I ^ce   White, C ^cf   Moller T R ^cg   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c Friuli Venezia Giulia Cancer Registry   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e Murcia Cancer Registry   (Spain)

^f Austrian National Cancer Registry)   (Austria)

^g Belgian Cancer Registry   (Belgium)

^h European Cancer Patient Coalition   (Belgium)

ⁱ Cancer Registry of Bas Rhin   (France)

^j Doubs Cancer Registry   (France)

^k Haut Rhin Cancer Registry   (France)

^l Herault Cancer Registry   (France)

^m Isere's Cancer Registry   (France)

ⁿ Manche Cancer Registry   (France)

^o Somme Cancer Registry   (France)

^p Tarn Cancer Registry   (France)

^q Connective Tissue Cancer Network – CONTICANET) ^*  (France)

^r SAARLAND CANCER REGISTRY   (Germany)

^s CML Advocates Network   (Germany)

^t Global GIST Network   (Germany)

^u ICELANDIC CANCER REGISTRY   (Iceland)

^v National Cancer Registry of Ireland   (Ireland)

^w Alto Adige Cancer Registry   (Italy)

^x Ferrara Cancer Registry   (Italy)

^y UNIVERSITY OF GENOA   (Italy)

^z Macerata Province Cancer Registry   (Italy)

^aa MODENA CANCER REGISTRY   (Italy)

^ab Napoli Cancer Registry   (Italy)

^ac PARMA CANCER REGISTRY   (Italy)

^ad Piedmont Cancer Registry   (Italy)

^ae CIVILE M P AREZZO HOSPITAL   (Italy)

^af S MARIA NUOVA HOSPITAL   (Italy)

^ag Romagna Cancer Institute   (Italy)

^ah Salerno Cancer Registry   (Italy)

^ai Sassari Cancer Registry   (Italy)

^aj Osservatorio Epidemiologico   (Italy)

^ak Tuscan Cancer Registry   (Italy)

^al Umbria Cancer Registry   (Italy)

^am Varese Cancer Registry   (Italy)

^an Veneto Cancer Registry   (Italy)

^ao Fondazione IRCCS Istituto Nazionale dei Tumori ^*

^ap Malta National Cancer Registry   (Malta)

^aq CANCER REGISTRY OF NORWAY   (Norway)

^ar Cracow Cancer Registry   (Poland)

^as Cancer Registry of Kielce   (Poland)

^at INSTITUTE OF ONCOLOGY   (Poland)

^au NATIONAL MEDICINES INSTITUTE   (Poland)

^av MEDICAL UNIVERSITY OF SILESIA   (Poland)

^aw Southern Portugal Cancer Registry   (Portugal)

^ax National Cancer Registry of   (Slovakia)

^ay INSTITUTE OF ONCOLOGY   (Slovenia)

^az Albacete Cancer Registry   (Spain)

^ba Basque Country Cancer Registry   (Spain)

^bb Castillon Cancer Registry   (Spain)

^bc Girona Cancer Registry   (Spain)

^bd Navarra Cancer Registry   (Spain)

^be Tarragona Cancer Registry   (Spain)

^bf ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^bg UNIVERSITY OF VALENCIA   (Spain)

^bh Regional Cancer Center Stockholm and Gotland   (Sweden)

^bi Regional Cancer Center Uppsala Orebro   (Sweden)

^bj KAROLINSKA INSTITUTE   (Sweden)

^bk Cancer Registry of Basel   (Switzerland)

^bl GENEVA CANCER REGISTRY   (Switzerland)

^bm St Gallen Cancer Registry   (Switzerland)

^bn Ticino Cancer Registry   (Switzerland)

^bo Valais Cancer Registry   (Switzerland)

^bp National Institute for Cancer Epidemiology and Registration   (Switzerland)

^bq Cancer Center Amsterdam   (Netherlands)

^br Erasmus University Rotterdam and Eindhoven Cancer Registry   (Netherlands)

^bs Cancer Genomics Centre Netherlands   (Netherlands)

^bt MAASTRICHT UNIVERSITY   (Netherlands)

^bu Eastern Cancer Registration and Information Centre   (United Kingdom)

^bv Northern and Yorkshire Cancer Registry   (United Kingdom)

^bw UNIVERSITY OF OXFORD   (United Kingdom)

^bx Oxford Cancer Intelligence Unit ^*  (United Kingdom)

^by Trent Cancer Registry   (United Kingdom)

^bz W Midlands Cancer Intelligence Unit   (United Kingdom)

^ca LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^cb UNIVERSITY COLLEGE LONDON   (United Kingdom)

^cc Northern Ireland Cancer Registry   (United Kingdom)

^cd Scottish Cancer Registry   (United Kingdom)

^ce UNIVERSITY OF EDINBURGH   (United Kingdom)

^cf Welsh Cancer Intelligence Surveillance Unit   (United Kingdom)

^cg LUND UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Bone sarcomas; Gastrointestinal stromal tumour; Incidence; Prevalence; Rare cancers; Soft tissue sarcomas; Survival

Indexed keywords

ANGIOSARCOMA; ARTICLE; BREAST SARCOMA; CANCER INCIDENCE; CANCER SURVIVAL; EUROPE; GASTROINTESTINAL STROMAL TUMOR; HEMANGIOENDOTHELIOMA; HEMANGIOPERICYTOMA; HUMAN; LEIOMYOSARCOMA; LIPOSARCOMA; LYMPHANGIOSARCOMA; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; OSTEOSARCOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SARCOMA; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; UTERUS SARCOMA;

EID: 84872678571     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.09.011     Document Type: Article

References (31)

1. J.R. Toro, L.B. Travis, H.J. Wu, K. Zhu, C.D.M. Fletcher, and S.S. Devesa Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases Int J Cancer 119 12 2006 2922 2930
2. M. Sant, C. Allemani, and M. Santaquilani EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary Eur J Cancer 45 6 2009 931 991
3. L.J. Helman, and P. Meltzer Mechanisms of sarcoma development Nat Rev Cancer 3 9 2003 685 694
4. N.M. Lindor, M.L. McMaster, C.J. Lindor, and M.H. Greene Concise handbook of familial cancer susceptibility syndromes. Second edition J Natl Cancer Inst Monogr 38 2008 1 93
5. L. Mirabello, R.J. Troisi, and S.A. Savage Osteosarcoma incidence and survival rates from 1973 to 2004. Data from the surveillance, epidemiology, and end results program Cancer 115 7 2009 1531 1543
6. R. Capocaccia, M. Colonna, and I. Corazziari Measuring cancer prevalence in Europe: the EUROPREVAL project Ann Oncol 13 6 2002 831 839
7. R. Capocaccia, and R. De Angelis Estimating the completeness of prevalence based on cancer registry data Stat Med 16 4 1997 425 440
8. T. Hakulinen Cancer survival corrected for heterogeneity in patient withdrawal Biometrics 38 4 1982 933 942
9. H. Brenner, and O. Gefeller An alternative approach to monitoring cancer patient survival Cancer 78 9 1996 2004 2010
10. R. De Angelis, R. Capocaccia, T. Hakulinen, B. Soderman, and A. Verdecchia Mixture models for cancer survival analysis: application to population-based data with covariates Stat Med 18 4 1999 441 454
11. S. Daugaard Current soft-tissue sarcoma classifications Eur J Cancer 40 4 2004 543 548
12. L. Mirabello, R.J. Troisi, and S.A. Savage International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons Int J Cancer 125 1 2009 229 234
13. K.P. Anfinsen, S.S. Devesa, and F. Bray Age-period-cohort analysis of primary bone cancer incidence rates in the United States (1976-2005) Cancer Epidemiol Biomarkers Prev 20 8 2011 1770 1777
14. J.-Y. Blay A decade of tyrosine kinase inhibitor therapy: historical and current perspectives on targeted therapy for GIST Cancer Treat Rev 37 5 2011 373 384
15. B. Nilsson, P. Bümming, and J.M. Meis-Kindblom Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western Sweden Cancer 103 4 2005 821 829
16. W.G. Goettsch, S.D. Bos, N. Breekveldt-Postma, M. Casparie, R.M. Herings, and P.C. Hogendoorn Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study Eur J Cancer 41 18 2005 2868 2872
17. G. Tryggvason, H.G. Gislason, M.K. Magnússon, and J.G. Jónasson Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study Int J Cancer 117 2 2005 289 293
18. J. Rubió, R. Marcos-Gragera, and M.R. Ortiz Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain Eur J Cancer 43 1 2007 144 148
19. C. Mucciarini, G. Rossi, and F. Bertolini Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study BMC Cancer 20 7 2007 230
20. A. Ferrari, I. Sultan, and T.T. Huang Soft tissue sarcoma across the age spectrum: a population-based study from the surveillance epidemiology and end results database Pediatr Blood Cancer 57 6 2011 943 949
21. A.Y. Giuffrida, J.E. Burgueno, L.G. Koniaris, J.C. Gutierrez, R. Duncan, and S.P. Scully Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database J Bone Joint Surg Am 91 5 2009 1063 1072
22. H.H. Storm EUROCARE Working Group Survival of adult patients with cancer of soft tissues or bone in Europe Eur J Cancer 34 14 1998 2212 2217
23. C.A. Stiller, A.W. Craft, I. Corazziari EUROCARE Working Group Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study Eur J Cancer 37 6 2001 760 766
24. C.A. Stiller, S.S. Bielack, G. Jundt, and E. Steliarova-Foucher Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project Eur J Cancer 42 13 2006 2124 2135
25. I. Ray-Coquard, P. Thiesse, and D. Ranchère-Vince Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas Ann Oncol 15 2 2004 307 315
26. A.A. Bhangu, J.A.S. Beard, and R.J. Grimer Should soft tissue sarcomas be treated at a specialist centre? Sarcoma 8 1 2004 1 6
27. C.A. Stiller, S.J. Passmore, M.E. Kroll, P.A. Brownbill, J.C. Wallis, and A.W. Craft Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994 Br J Cancer 94 1 2006 22 29
28. J.C. Gutierrez, E.A. Perez, F.L. Moffat, A.S. Livingstone, D. Franceschi, and L.G. Koniaris Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients Ann Surg 245 6 2007 952 958
29. J.K. Chan, N.M. Kawar, and J.Y. Shin Endometrial stromal sarcoma: a population-based analysis Br J Cancer 99 2008 1210 1215
30. S. Stacchiotti, A. Longhi, and V. Ferraresi Phase II study of imatinib in advanced chordoma J Clin Oncol 30 2012 914 920
31. S. Stacchiotti, T. Negri, and N. Zaffaroni Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect Ann Oncol 22 2011 1682 1690